GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sailong Pharmaceutical Group Co Ltd (SZSE:002898) » Definitions » Gross Profit

Sailong Pharmaceutical Group Co (SZSE:002898) Gross Profit : ¥128.5 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sailong Pharmaceutical Group Co Gross Profit?

Sailong Pharmaceutical Group Co's gross profit for the three months ended in Mar. 2024 was ¥27.6 Mil. Sailong Pharmaceutical Group Co's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was ¥128.5 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Sailong Pharmaceutical Group Co's gross profit for the three months ended in Mar. 2024 was ¥27.6 Mil. Sailong Pharmaceutical Group Co's Revenue for the three months ended in Mar. 2024 was ¥69.5 Mil. Therefore, Sailong Pharmaceutical Group Co's Gross Margin % for the quarter that ended in Mar. 2024 was 39.74%.

Sailong Pharmaceutical Group Co had a gross margin of 39.74% for the quarter that ended in Mar. 2024 => Competition eroding margins

During the past 11 years, the highest Gross Margin % of Sailong Pharmaceutical Group Co was 74.25%. The lowest was 42.74%. And the median was 56.42%.

Warning Sign:

Sailong Pharmaceutical Group Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -5.5%.


Sailong Pharmaceutical Group Co Gross Profit Historical Data

The historical data trend for Sailong Pharmaceutical Group Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sailong Pharmaceutical Group Co Gross Profit Chart

Sailong Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 217.91 77.38 163.62 141.25 143.47

Sailong Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.58 40.54 31.70 28.65 27.61

Competitive Comparison of Sailong Pharmaceutical Group Co's Gross Profit

For the Biotechnology subindustry, Sailong Pharmaceutical Group Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sailong Pharmaceutical Group Co's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sailong Pharmaceutical Group Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Sailong Pharmaceutical Group Co's Gross Profit falls into.



Sailong Pharmaceutical Group Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Sailong Pharmaceutical Group Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=310.627 - 167.16
=143.5

Sailong Pharmaceutical Group Co's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=69.484 - 41.874
=27.6

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥128.5 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Sailong Pharmaceutical Group Co's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=27.6 / 69.484
=39.74 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Sailong Pharmaceutical Group Co  (SZSE:002898) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Sailong Pharmaceutical Group Co had a gross margin of 39.74% for the quarter that ended in Mar. 2024 => Competition eroding margins


Sailong Pharmaceutical Group Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Sailong Pharmaceutical Group Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Sailong Pharmaceutical Group Co (SZSE:002898) Business Description

Traded in Other Exchanges
N/A
Address
No. 47, Haibin South Road, 2nd Floor, Everbright International Trade Center, Guangdong Province, Zhuhai, CHN, 519015
Zhuhai Sailong Pharmaceutical Co Ltd is the pharmaceutical company. It is mainly engaged in the development, production, marketing and technical services of pharmaceuticals. The company's products are mainly concentrated in the fields of the nervous system, cardiovascular and digestive system. The product range includes monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others.
Executives
Tang Lin Director
Long Zhi Xiang Director
Deng Yong Jun Supervisors
Zhou Bei Supervisors
Li Jian Feng Directors, executives

Sailong Pharmaceutical Group Co (SZSE:002898) Headlines

No Headlines